PKN2 and breast cancer: As with PRK1, PRK2 expression did not correlate with poorer survival across all breast cancer patients (Fig. 4B, PRK2 panel); however, there was a significant correlation (p = 0.025) between higher PRK2 expression and poor survival probability in patients with Basal-like/TNBC.